Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Researchers develop self-assembling nanoparticle SARS-CoV-2 vaccines

Researchers in China have developed three SARS-CoV-2 nanoparticle vaccines, containing receptor-binding domain (RBD) trimer, S1 trimer, and ectodomain (ECD) trimer, respectively. To do this, they have used Ferritin nanoparticle self-assembly technology.

9 Feb 2021

Smell and taste loss symptoms associated with robust SARS-CoV-2 antibody response in new study

Researchers in Italy report a correlation between the loss of smell and taste and an observed persistence or rise in antibody levels at five months after infection.

9 Feb 2021

Native Americans use technology to keep traditions, language alive during pandemic

Lawrence Wetsit misses the days when his people would gather by the hundreds and sing the songs that all Assiniboine children are expected to learn by age 15.

9 Feb 2021

Vaccinated mothers may pass on SARS-CoV-2 antibodies to newborns

A new study describes the first case of anti-SARS-CoV-2 antibodies detected in the cord blood of an infant born to a mother immunized with the first dose of an mRNA COVID-19 vaccine three weeks earlier.

9 Feb 2021

Delayed reactions and decentralized approach on 1918 pandemic had more fatal consequences

In the event of a pandemic, delayed reactions and a decentralized approach by the authorities at the start of a follow-up wave can lead to longer-lasting, more severe and more fatal consequences, researchers from the universities of Zurich and Toronto have found.

9 Feb 2021

Wearable devices can identify COVID-19 cases earlier than traditional diagnostic methods

Wearable devices can identify COVID-19 cases earlier than traditional diagnostic methods and can help track and improve management of the disease, Mount Sinai researchers report in one of the first studies on the topic. The findings were published in the Journal of Medical Internet Research on January 29.

8 Feb 2021

History of vaccines offers guidance on COVID-19 prevention in pregnant women

Pregnant women, who are at increased risk of preterm birth or pregnancy loss if they develop a severe case of COVID-19, need the best possible guidance on whether they should receive a COVID-19 vaccine, according to an article by two UT Southwestern obstetricians published today in JAMA.

8 Feb 2021

Study shows efficacy of radionuclide therapy–immunotherapy combination in prostate cancer model

A combination of radionuclide therapy and immunotherapy has proven successful in slowing the progression of prostate cancer and increasing survival time, according to new research published in the February issue of The Journal of Nuclear Medicine.

8 Feb 2021

Research from Israel shows mRNA vaccine is ~50% effective in reducing severe cases

In a report published on the pre-print server medRxiv, researchers at The Hebrew University of Jerusalem, the University of Trento, and the Racah Institute of Physics suggest that the shape of the outbreak in patients over 60 years old has changed because of the vaccinations.

8 Feb 2021

Americans plan to continue many of the pandemic precautions even after COVID-19

A new national survey of more than 2,000 Americans by The Ohio State University Wexner Medical Center finds most plan to continue many of the pandemic precautions in the name of public health, even when the pandemic is over.

8 Feb 2021

COVID-19 pandemic and nanotechnology

Writing in the International Journal of Nanomedicine, Professor Dongki Yang, from the Department of Physiology, Gachon University, South Korea, has reviewed the available knowledge on the coronaviruses, current approaches to tackle the newly emerged SARS-CoV-2 infection, and the innovative application of nanotechnology in the COVID-19 pandemic.

8 Feb 2021

Novel plastic film can deactivate 99.99% of the new coronavirus in 15 minutes

A consortium comprised by companies Braskem, AplFilm and Nanox and the UFSCar (Brazil) and Jaume I of Castellón (Spain) universities have released a plastic film capable of deactivating 99.99% of the new coronavirus in 15 minutes.

8 Feb 2021

Commentary on severe allergic reaction to mRNA SARS-CoV-2 vaccines

A commentary by John M. Kelso, Division of Allergy, Asthma and Immunology, Scripps Clinic, published in the latest issue of the journal Vaccines, discusses anaphylactic reactions to these novel mRNA SARS-CoV-2/COVID-19 vaccines.

8 Feb 2021

Symptomatic COVID-19 cases extremely low among YMCA summer campers in North Carolina

Cases of symptomatic COVID-19 were extremely low among children and staff at a network of YMCA summer camps held last year in North Carolina that took precautions like masking and physical distancing, with close to zero transmissions occurring at the camps, according to researchers at Duke Health, Weill Cornell Medicine and NewYork-Presbyterian.

7 Feb 2021

Anticancer drug may reduce mortality and speed up recovery for severe COVID-19 patients

Treating severe COVID-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, according to a small clinical study in Italy and China that was led by researchers at Karolinska Institutet in Sweden between February and April 2020.

6 Feb 2021

Researchers develop systems to detect an atypical fungus responsible for severe pneumonia

The group led by Dr. Enrique J. Calderón - "Clinical Epidemiology and Vascular Risk" at the Institute of Biomedicine of Seville - IBiS/University Hospitals Virgen del Rocío and Macarena/CSIC/University of Seville, also a member of CIBERESP, participated in a project with researchers from CIBER-BBN, in which they developed systems to detect Pneumocystis jirovecii, an atypical fungus responsible for very severe pneumonia in immunosuppressed patients.

6 Feb 2021

$FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma$

FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.

5 Feb 2021

Comparing death tolls from covid to past wars is fraught

Counting the dead is one of the first, somber steps in reckoning with an event of enormous tragic scope, be it war, a natural disaster or a pandemic.

5 Feb 2021

FDA continues to support the development of medical products to tackle new virus variants

As the public health agency responsible for regulating medical products, we must ensure that health care providers have the most up-to-date diagnostics, treatments and vaccines in their toolbox to fight this pandemic.

5 Feb 2021

Natural reinfection with respiratory syncytial virus varies based on antibody response

Researchers at Baylor College of Medicine found that while most individuals responded to respiratory syncytial virus (RSV) natural reinfection with a typical sustained antibody response associated with protection, a few individuals surprisingly responded atypically, not being able to sustain the antibody response, which declined to levels that made the individuals susceptible to RSV reinfection.

5 Feb 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Researchers develop self-assembling nanoparticle SARS-CoV-2 vaccines

Smell and taste loss symptoms associated with robust SARS-CoV-2 antibody response in new study

Native Americans use technology to keep traditions, language alive during pandemic

Vaccinated mothers may pass on SARS-CoV-2 antibodies to newborns

Delayed reactions and decentralized approach on 1918 pandemic had more fatal consequences

Wearable devices can identify COVID-19 cases earlier than traditional diagnostic methods

History of vaccines offers guidance on COVID-19 prevention in pregnant women

Study shows efficacy of radionuclide therapy–immunotherapy combination in prostate cancer model

Research from Israel shows mRNA vaccine is ~50% effective in reducing severe cases

Americans plan to continue many of the pandemic precautions even after COVID-19

COVID-19 pandemic and nanotechnology

Novel plastic film can deactivate 99.99% of the new coronavirus in 15 minutes

Commentary on severe allergic reaction to mRNA SARS-CoV-2 vaccines

Symptomatic COVID-19 cases extremely low among YMCA summer campers in North Carolina

Anticancer drug may reduce mortality and speed up recovery for severe COVID-19 patients

Researchers develop systems to detect an atypical fungus responsible for severe pneumonia

FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

Comparing death tolls from covid to past wars is fraught

FDA continues to support the development of medical products to tackle new virus variants

Natural reinfection with respiratory syncytial virus varies based on antibody response

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in